Literature DB >> 17393124

Superparamagnetic iron oxide labeling of neural stem cells and 4.7T MRI tracking in vivo and in vitro.

Wenzhen Zhu1, Xiang Li, Zhouping Tang, Suiqiang Zhu, Jianpin Qi, Li Wei, Hao Lei.   

Abstract

Neural stem cells were labeled with superparamagnetic iron oxide (SPIO) and tracked by MRI in vitro and in vivo after implantation. Rat neural stem cells were labeled with SPIO combined with PLL by the means of receptor-mediated endocytosis. Prussian blue staining and electron microscopy were conducted to identify the iron particles in these neural stem cells. SPIO-labeled cells were tracked by 4.7T MRI in vivo and in vitro after implantation. The subjects were divided into 5 groups, including 5 x 10(5) labeled cells cultured for one day after labeling, 5 x 10(5) same phase unlabeled cells, cell culture medium with 25 mug Fe/mL SPIO, cell culture medium without SPIO and distilled water. MRI scanning sequences included T(1)WI, T(2)WI and T(2)*WI. R(2) and R(2)* of labeled cells were calculated. The results showed: (1) Neural stem cells could be labeled with SPIO and labeling efficiency was 100%. Prussian blue staining showed numerous blue-stained iron particles in the cytoplasm; (2) The average percentage change of signal intensity of labeled cells on T(1)WI in 4.7T MRI was 24.06%, T2WI 50.66% and T(2)*WI 53.70% respectively; (3) T2 of labeled cells and unlabeled cells in 4.7T MRI was 516 ms and 77 ms respectively, R(2) was 1.94 s(-1) and 12.98 s(-1) respectively, and T(2)* was 109 ms and 22.9 ms, R(2)* was 9.17 s(-1) and 43.67 s(-1) respectively; (4) Remarkable low signal area on T(2)WI and T(2)*WI could exist for nearly 7 weeks and then disappeared gradually in the left brain transplanted with labeled cells, however no signal change in the right brain implanted with unlabeled cells. It was concluded that neural stem cells could be labeled effectively with SPIO. R2 and R(2)* of labeled cells were increased obviously. MRI can be used to track labeled cells in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393124     DOI: 10.1007/s11596-007-0130-1

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  11 in total

1.  Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS.

Authors:  A Villa; E Y Snyder; A Vescovi; A Martínez-Serrano
Journal:  Exp Neurol       Date:  2000-01       Impact factor: 5.330

2.  Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination.

Authors:  J W Bulte; S Zhang; P van Gelderen; V Herynek; E K Jordan; I D Duncan; J A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging.

Authors:  Michel Modo; Diana Cash; Karen Mellodew; Steven C R Williams; Scott E Fraser; Thomas J Meade; Jack Price; Helen Hodges
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

4.  [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T].

Authors:  H Ittrich; C Lange; H Dahnke; A R Zander; G Adam; C Nolte-Ernsting
Journal:  Rofo       Date:  2005-08

5.  Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency.

Authors:  Lars Matuszewski; Thorsten Persigehl; Alexander Wall; Wolfram Schwindt; Bernd Tombach; Manfred Fobker; Christopher Poremba; Wolfgang Ebert; Walter Heindel; Christoph Bremer
Journal:  Radiology       Date:  2005-03-04       Impact factor: 11.105

6.  [Labeling neural stem cells with superparamagnetic iron oxide in vitro and tracking after implantation with MRI in vivo].

Authors:  Meng Jing; Xin-quan Liu; Peng Liang; Chang-yu Li; Xiang-tong Zhang; Dan Wang; Yu Luan; En-zhong Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2004-08-17

7.  Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.

Authors:  Ali S Arbab; Lindsey A Bashaw; Bradley R Miller; Elaine K Jordan; Bobbi K Lewis; Heather Kalish; Joseph A Frank
Journal:  Radiology       Date:  2003-12       Impact factor: 11.105

8.  Targeting of hematopoietic progenitor cells with MR contrast agents.

Authors:  Heike E Daldrup-Link; Martina Rudelius; Robert A J Oostendorp; Marcus Settles; Guido Piontek; Stefan Metz; Hilkea Rosenbrock; Ulrich Keller; Ulrich Heinzmann; Ernst J Rummeny; Jürgen Schlegel; Thomas M Link
Journal:  Radiology       Date:  2003-07-24       Impact factor: 11.105

9.  Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat.

Authors:  Mathias Hoehn; Ekkehard Küstermann; James Blunk; Dirk Wiedermann; Thorsten Trapp; Stefan Wecker; Melanie Föcking; Heinz Arnold; Jürgen Hescheler; Bernd K Fleischmann; Wolfram Schwindt; Christian Bührle
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

10.  Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.

Authors:  Joseph A Frank; Brad R Miller; Ali S Arbab; Holly A Zywicke; E Kay Jordan; Bobbi K Lewis; L Henry Bryant; Jeff W M Bulte
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

View more
  8 in total

Review 1.  Mesenchymal stem cells engineered for cancer therapy.

Authors:  Khalid Shah
Journal:  Adv Drug Deliv Rev       Date:  2011-06-29       Impact factor: 15.470

2.  Viability, differentiation capacity, and detectability of super-paramagnetic iron oxide-labeled muscle precursor cells for magnetic-resonance imaging.

Authors:  Fahd Azzabi; Markus Rottmar; Virginija Jovaisaite; Markus Rudin; Tullio Sulser; Andreas Boss; Daniel Eberli
Journal:  Tissue Eng Part C Methods       Date:  2014-08-04       Impact factor: 3.056

3.  Magnetic resonance imaging of cells in experimental disease models.

Authors:  Naser Muja; Jeff W M Bulte
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-07       Impact factor: 9.795

4.  Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™.

Authors:  Benjamin Addicott; Melissa Willman; Jose Rodriguez; Kyle Padgett; Dongmei Han; Dora Berman; Joshua M Hare; Norma Sue Kenyon
Journal:  Contrast Media Mol Imaging       Date:  2010-08-05       Impact factor: 3.161

Review 5.  Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?

Authors:  Catherine Tang; Pamela J Russell; Rosetta Martiniello-Wilks; John E J Rasko; Aparajita Khatri
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

6.  Methodological aspects of MRI of transplanted superparamagnetic iron oxide-labeled mesenchymal stem cells in live rat brain.

Authors:  Daria Namestnikova; Ilya Gubskiy; Irina Kholodenko; Pavel Melnikov; Kirill Sukhinich; Anna Gabashvili; Daniil Vishnevskiy; Anastasia Soloveva; Maxim Abakumov; Igor Vakhrushev; Alexei Lupatov; Vladimir Chekhonin; Leonid Gubsky; Konstantin Yarygin
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

7.  Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington's disease.

Authors:  Jaisan Islam; Kyoung Ha So; Elina Kc; Hyeong Cheol Moon; Aryun Kim; Sang Hwan Hyun; Soochong Kim; Young Seok Park
Journal:  Stem Cell Res Ther       Date:  2021-11-22       Impact factor: 6.832

8.  Dose-response of superparamagnetic iron oxide labeling on mesenchymal stem cells chondrogenic differentiation: a multi-scale in vitro study.

Authors:  Emilie Roeder; Christel Henrionnet; Jean Christophe Goebel; Nicolas Gambier; Olivier Beuf; Denis Grenier; Bailiang Chen; Pierre-André Vuissoz; Pierre Gillet; Astrid Pinzano
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.